A Clinical Study of SHR-9839 as Monotherapy or in Combination With Chemotherapy Plus Adebrelimab Versus Chemotherapy Plus Adebrelimab in Patients With Advanced Esophageal Squamous Cell Carcinoma
Clinical trial NCT07751341 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07751341
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2027-12-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.